Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Neuvonen

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Therapeutic Drug Monitoring|June 4, 2008
Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometryMikko Neuvonen, Pertti J Neuvonen
British Journal of Clinical Pharmacology|June 23, 2004
Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinJari J Lilja, Mikko Neuvonen, Pertti J Neuvonen
Basic & Clinical Pharmacology & Toxicology|August 4, 2023
Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitorsFeng Deng, Johanna Sistonen, Mikko Neuvonen, et al.
Journal of Clinical Pharmacology|January 12, 2008
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinideAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemiaMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|October 1, 2008
The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose rangeAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|July 20, 2007
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazoneAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 15, 2025
Transport of statins by multidrug resistance-associated proteins 1 and 5Suvi-Kukka Tuomi, Feng Deng, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjectsMikko Niemi, Janne T Backman, Mikko Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2025
Comparative uptake of statins by hepatic organic anion transporting polypeptidesWilma Kiander, Alli Sinokki, Mikko Neuvonen, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Therapeutic Drug Monitoring|June 4, 2008
Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometryMikko Neuvonen, Pertti J Neuvonen
British Journal of Clinical Pharmacology|June 23, 2004
Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinJari J Lilja, Mikko Neuvonen, Pertti J Neuvonen
Basic & Clinical Pharmacology & Toxicology|August 4, 2023
Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitorsFeng Deng, Johanna Sistonen, Mikko Neuvonen, et al.
Journal of Clinical Pharmacology|January 12, 2008
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinideAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemiaMia Hedman, Pertti J Neuvonen, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|October 1, 2008
The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose rangeAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
British Journal of Clinical Pharmacology|July 20, 2007
No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazoneAnnikka Kalliokoski, Mikko Neuvonen, Pertti J Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 15, 2025
Transport of statins by multidrug resistance-associated proteins 1 and 5Suvi-Kukka Tuomi, Feng Deng, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjectsMikko Niemi, Janne T Backman, Mikko Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2025
Comparative uptake of statins by hepatic organic anion transporting polypeptidesWilma Kiander, Alli Sinokki, Mikko Neuvonen, et al.
Pageof 11